Global  

Oxford Covid vaccine: AstraZeneca still waiting for FDA nod to resume US trial

WorldNews Thursday, 24 September 2020
Oxford Covid vaccine: AstraZeneca still waiting for FDA nod to resume US trialAstraZeneca is still waiting for the U.S. drug regulator to approve the restart of the clinical trial of its potential COVID-19 vaccine in the United States almost three weeks after it was paused due to safety concerns. The U.S. trial of AstraZeneca's COVID-19 vaccine candidate, initially developed by the University of Oxford, remains on hold...
0
shares
ShareTweetSavePostSend
 
Video Credit: HT Digital Content - Published
News video: EJ Espresso: UK will infect volunteers with Covid to test vaccine

EJ Espresso: UK will infect volunteers with Covid to test vaccine 07:15

J&J kicks off final trial of single-shot Covid vaccine. UK will infect volunteers with Covid to test vaccine. Rape case against Anurag Kashyap on actor's complaint. And have you seen ex-Bihar DGP's 'Robinhood Pandey' avatar. All the news and updates for you in this editorji playlist.

💡 One News Page Knowledge: Other News Mentions

AstraZeneca British-Swedish pharmaceutical company

Global COVID-19 cases rise by a one-day record [Video]

Global COVID-19 cases rise by a one-day record

Global coronavirus cases rose by more than 400,000 for the first time late on Friday, a record one-day increase as much of Europe enacts new restrictions to curb the outbreak. Freddie Joyner has more.

Credit: Reuters - Politics    Duration: 01:18Published

Russian disinformation aims to sow distrust over coronavirus vaccines

On Russian state television in September, the Oxford-AstraZeneca coronavirus vaccine was described as a "monkey vaccine" and portrayed as downright dangerous...
CBS News

Britain's spies defending COVID-19 vaccine work, MI5 chief says

By Guy Faulconbridge LONDON (Reuters) - British spies are trying to defend COVID-19 vaccine work against hostile powers that seek to either steal or sabotage..
WorldNews

Covid-19: Oxford vaccine phase three results by November-December

The results of phase three trials of the Oxford-AstraZeneca vaccine being conducted in India could be available by “end-November-early December”, raising..
IndiaTimes
Could AstraZeneca profit from vaccine by July? [Video]

Could AstraZeneca profit from vaccine by July?

AstraZeneca could start profiting from its COVID-19 vaccine as soon as July next year, the Financial Times has reported, citing a memo showing the British drugmaker can declare when it considers the pandemic to have ended. Ciara Lee reports

Credit: Reuters Studio    Duration: 01:12Published

Food and Drug Administration Food and Drug Administration Agency of the United States Department of Health and Human Services

California to review any COVID-19 vaccine [Video]

California to review any COVID-19 vaccine

An independent panel of experts has been formed in California to review any federally approved Covid-19 vaccine. The move follows concerns that the White House could rush the process. Flora Bradley-Watson reports.

Credit: Reuters - Politics    Duration: 01:25Published

Government agency will investigate Trump administration political influence over FDA, CDC

Both agencies have been caught in political crossfire since the start of the pandemic, as preventative health measures became politicized.

USATODAY.com
Twitter blocks post by top Trump pandemic adviser [Video]

Twitter blocks post by top Trump pandemic adviser

[NFA] Twitter took down a post by a top coronavirus task force adviser who questioned whether masks worked to cut down on transmission of the respiratory illness. This report produced by Zachary Goelman.

Credit: Reuters - Politics    Duration: 02:09Published

Gottlieb says "biggest wave" of coronavirus infections still to come

The former FDA commissioner says the U.S. has "two or three very hard months ahead of us."
CBS News

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

Melania Trump stays off campaign trail, citing lingering cough

The first lady has tested negative for COVID-19 since her initial diagnosis.
CBS News
PM defends funding for Tier 3 regions [Video]

PM defends funding for Tier 3 regions

Boris Johnson has defended the funding given to regions in Tier 3 Covid alert level, following a breakdown in negotiations with local leaders in Greater Manchester. Report by Etemadil. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 02:31Published

Covid: Greater Manchester to move to Tier 3 restrictions from Friday

Boris Johnson says he "regrets" a deal over financial support could not be reached with local leaders.
BBC News

University of Oxford University of Oxford Collegiate research university in Oxford, England

Covid: Oxford University cases triple on previous week

Almost 70% of positive cases at at the institution are confirmed in the week to 16 October.
BBC News
UK will get first access to Oxford vaccine, No 10 says [Video]

UK will get first access to Oxford vaccine, No 10 says

The UK would be first in line for a coronavirus vaccine developed by OxfordUniversity if it was proven to be effective, Downing Street has said. It comesafter reports Donald Trump is considering granting emergency authorisation forit to be deployed in the US.

Credit: PA - Press Association STUDIO    Duration: 02:20Published

You Might Like


Related videos from verified sources

Moderna's CEO Says Experimental COVID-19 Vaccine Might Get Approved In December [Video]

Moderna's CEO Says Experimental COVID-19 Vaccine Might Get Approved In December

Moderna's timetable isn't far off from Pfizer's, which said last week it expects to seek authorization of emergency use of its vaccine by late November.

Credit: CBS 2 New York     Duration: 00:25Published
Moderna Hopes For Coronavirus Vaccine Emergency Use By End Of Year [Video]

Moderna Hopes For Coronavirus Vaccine Emergency Use By End Of Year

WBZ TV's Anna Meiler reports.

Credit: WBZ CBS Boston     Duration: 00:23Published
Covid vaccine will not be available in UK before spring, says Sir Patrick Vallance – video [Video]

Covid vaccine will not be available in UK before spring, says Sir Patrick Vallance – video

It is unlikely a coronavirus vaccine will be in widespread use in Britain before next spring, the government's chief scientific adviser Patrick Vallance said on Monday. The Sunday Times had reported..

Credit: Guardian     Duration: 00:49Published

Related news from verified sources

Oxford Covid vaccine: AstraZeneca still waiting for FDA nod to resume US trial

Oxford Covid vaccine: AstraZeneca still waiting for FDA nod to resume US trial
AstraZeneca is still waiting for the U.S. drug regulator to approve the restart of the clinical trial of its potential COVID-19 vaccine in the United States...
WorldNews

AstraZeneca resumes coronavirus vaccine clinical trials, but only in the UK

AstraZeneca resumes coronavirus vaccine clinical trials, but only in the UK
AstraZeneca is partnering with the University of Oxford to develop and test a COVID-19 vaccine. | Photo by Paul Ellis / AFP via Getty Images A big vaccine...
The Verge Also reported by •WorldNewsBelfast TelegraphCBS NewsDNAIndiaTimes

DCGI sends show cause notice to Serum Institute for not pausing trial of COVID-19 vaccine

The central drug regulator has issued a show-cause notice to the Serum Institute of India (SII) for not informing it about pharma giant AstraZeneca pausing the...
Mid-Day Also reported by •bizjournals

Tweets about this